Agilent Technologies to OEM customers to build composite single crystal optical components development program
Agilent Technologies announced that OEM customers to build a compound single crystal optical components development program. The plan allows customers the opportunity to the latest high-precision optical design technology into their optical system design. CMO is an independent optical components, its design principle is to combine several discrete optical components into a single optical pre-school structure. Optical components for many applications is quite common and important component of zero, which can be embedded in manufacturing equipment and scientific instruments, imaging and display, medical, aerospace / defense and nanotechnology systems.
Agilent developed CMO aims to address stringent demand for interference measurement applications, such applications attaches great importance to system stability and minimal downtime. Traditionally, CMO has been regarded as a high-end solution. Many new applications on the total cost of ownership is a primary consideration, Agilent's CMO Development Program will help promote the design of these applications CMO. By reducing the amount of CMO parts and improve performance and reliability, achieved the objective of improving the efficiency of the optical system, are liable to have reduced the total cost of ownership, size and weight.
Today, Agilent has been completed according to design and build a variety of CMO myriad devices, leading to increasing industrial and commercial applications CMO solutions. Agilent CMO developed plans to invite its customers and its precision optical components group together to use the company's many years of experience producing CMO.
Optical system design usually use discrete optical components, these components must be individually installed to originally designed for scientific applications in optical and mechanical components, and to manually adjust. Under such an approach is feasible in the laboratory setting, because the technical staff to maintain the calibration and adjustment of environmental factors, but required a reliable system performance and stability of long-term commercial implementation is not appropriate. CMO is the next step in the evolution of the optical system design, it is more compact with a single, more efficient and economical to replace a large number of optical components components.
Agilent reports that third quarter 2007 the company obtained orders was 13.1 billion U.S. dollars, an increase of 7% over the same period last year. Revenues during the quarter was 13.7 billion U.S. dollars, an increase of 11% over the same period last year. In accordance with U.S. GAAP basis, third quarter revenue of 185 million U.S. dollars, 0.45 U.S. dollars per diluted share, compared to 065 million U.S. dollars, equivalent to 0.15 per share, assets, sales profit of 216 million U.S. dollars.
The company made in accordance with U.S. GAAP third quarter report included 27 million U.S. dollars in stock-based compensation expenses. Excluding these costs and 18 million U.S. dollars and other net income taxes, Agilent reported third quarter adjusted net income of 194 million U.S. dollars, equivalent to 0.48 U.S. dollars per share, compared to 1.66 U.S. dollars from the company, equivalent to 0.39 U.S. dollars per share.
Agilent President and CEO Sullivan (Bill Sullivan), said: "Despite the market trend in the third quarter was diverse, Agilent continues to achieve its strong growth. Bioanalytical measurement business was strong, our business and more robust performance. Electronic Measurement business market in the Americas and Europe have shown very stable, but in Asia, especially in Japan, but surprisingly showed weakness. "
"Therefore, the company earnings in the third quarter, 13.7 billion U.S. dollars, an increase of 11% over the same period last year, with our revised expectations of a slight deviation. Adjusted net income per share was 0.48 U.S. dollars, an increase of 23 over last year % to the range of our expectations. "
Sullivan noted that the acquisition of Stratagene, by the third quarter, the impact of the field of bio-analytical measurement business orders grew more than 21% over the same period last year, while revenue reached 500 million U.S. dollars, an increase of more than 19% over the same period last year. "Initial integration process is well advanced, we are very excited to be Stratagene's life science reagent and the combination of Agilent's analytical tools to the commercial and non-profit life science application areas to better serve customers. "
The third quarter rate of capital return of 28% as compared to the excellent performance was three percentage points higher, the number of days receivables and inventory holding days are shortened to 3 days. Operational activities, the number of cash acquired 1.76 million. During the third quarter, the company repurchased 677 million U.S. dollars of the company's common stock. Company to 1.5 billion in net cash count for the quarter and draw a satisfactory conclusion.
Looking ahead, given the weak Asian electronic measurement markets trend, Agilent expects the fourth quarter of 2007 will be slightly lower than the normal quarter revenue growth. Expected revenues from 1.39 to 1.43 billion U.S. dollars between the growth of 5% over last year to 8%. Adjusted net income is expected to 0.5 U.S. dollars per share to between 0.54 U.S. dollars per share, compared with last year rose 9% to 17%.
Sullivan said: "Recent Asian electronic measurement markets weak and does not reduce our Agilent in fiscal year 2008 performance expectations. We look forward to next year, biological analysis and measurement business market continues to remain strong, the electronic measurement business market can return to more normal long-term growth track. We will continue with our sound business model, from our core products, growth plans and acquisition of investment benefits. "
I am an expert from disposablemedicalsuppliers.com, while we provides the quality product, such as Disposable Forceps , Health Care Netipot, disposable medical exporter,and more.
Processing your request, Please wait....
